Bart Janssens is a member of the Health Care practice at Boston Consulting Group. He has over 20 years of experience advising biopharma and health care clients, and has been based in India for over 15 years.

Bart focuses on the generics sector. He has worked with his health care clients on the complete biopharma/generics value chain, including biosimilars, on projects covering R&D, operations, and supply chain productivity improvement, as well as direct and indirect cost reduction, mergers and acquisitions, post-merger integration, business unit growth strategy (in India and globally), and corporate portfolio strategy and capital allocation.


  • MBA, University of Chicago Booth School of Business
  • Masters in Applied Economics, Katholieke Universiteit Leuven (Belgium)